SERA Stock Summary and Trading Ideas (Sera Prognostics - Class A | NASDAQ:SERA)

Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Sera Prognostics - Class A trades on the NASDAQ stock market under the symbol SERA.

As of July 17, 2026, SERA stock price declined to $2.05 with 19,511 million shares trading.

SERA has a beta of 1.85, meaning it tends to be more sensitive to market movements. SERA has a correlation of 0.07 to the broad based SPY ETF.

SERA has a market cap of $80.24 million. This is considered a Micro Cap stock.

Last quarter Sera Prognostics - Class A reported $14,000 in Revenue and -$.17 earnings per share. This fell short of revenue expectation by $-69,336 and met earnings estimates .

In the last 3 years, SERA traded as high as $12.36 and as low as $1.37.

The top ETF exchange traded funds that SERA belongs to (by Net Assets): VTI, VXF, IWC, AVSC, DCOR.

SERA has underperformed the market in the last year with a return of -31.7%, while the SPY ETF gained +19.5%. In the last 3 month period, SERA fell short of the market, returning -10.9%, while SPY returned +4.9%. However, in the most recent 2 weeks SERA has outperformed the stock market by returning +2.5%, while SPY returned -0.2%.

SERA support price is $2.04 and resistance is $2.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SERA shares will trade within this expected range on the day.